Cost-benefit calculations of vaccinations against measles and mumps in Austria.
The analysis of combined measles-mumps vaccination in Austria showed that this measure is highly profitable in economical respect. The benefit-cost ratio Qc amounts to 2.65 without and 4.48 with consideration of the so-called "nursing vacation", a one week's vacation which is being granted in Austria to employed mothers for the nursing of a sick child once a year. The benefit-cost difference Dc amounts to AS 672.85 OF 1,681.90 respectively, per child. Twelve years after the beginning of vaccination of 100,000 one year old children per year which corresponds roughly to the birth rate in Austria an amount of 63 mill. AS can be saved, if "nursing vacations" are not considered. This amount will be even 528 mill. AS, if "nursing vacations" are taken in account.
D001317:Austria; D002648:Child; D003362:Cost-Benefit Analysis; D006801:Humans; D008457:Measles / Q000191:economics / Q000517:prevention & control*; D008458:Measles Vaccine / Q000627:therapeutic use; D009107:Mumps / Q000191:economics / Q000517:prevention & control*; D009108:Mumps Vaccine / Q000627:therapeutic use; D014611:Vaccination / Q000191:economics*
D008458:Measles Vaccine; D009108:Mumps Vaccine